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Mutations in the SPARC-Related Modular
Calcium-Binding Protein 1 Gene, SMOC1,
Cause Waardenburg Anophthalmia Syndrome
Hana Abouzeid,1,2,7 Gae¨lle Boisset,1,7 Tatiana Favez,1 Mohamed Youssef,3 Iman Marzouk,3
Nihal Shakankiry,4 Nader Bayoumi,4 Patrick Descombes,5 Ce´line Agosti,1 Francis L. Munier,1,2
and Daniel F. Schorderet1,2,6,*
Waardenburg anophthalmia syndrome, also known as microphthalmia with limb anomalies, ophthalmoacromelic syndrome,
and anophthalmia-syndactyly, is a rare autosomal-recessive developmental disorder that has been mapped to 10p11.23. Here we
show that this disease is heterogeneous by reporting on a consanguineous family, not linked to the 10p11.23 locus, whose two affected
children have a homozygous mutation in SMOC1. Knockdown experiments of the zebrafish smoc1 revealed that smoc1 is important in
eye development and that it is expressed in many organs, including brain and somites.Anophthalmia describes a rare developmental anomaly in
which the eye is absent as the result of a deficiency in the
development of the primary optic vesicles. Severe micro-
phthalmia occurs at a prevalence of 3 in 10,000. Micro-
phthalmia can be isolated or syndromic. Genetic studies
of isolated cases have identified mutations in, among
others, RAX,1 VSX22 (MIM 142993) PAX63 (MIM
607106), MITF4 (MIM 156845), MAF5 (MIM 177075),
OTX26 (MIM 600037), SOX27 (MIM 184429), and SIX68
(MIM 606326). All these genes play a role in early ocular
development. Mutations in members of the Wnt signaling
and TGF-b1 (MIM 190180) superfamily, including
members of the bone morphogenetic proteins and
growth-differentiation factors, have also been impli-
cated.9,10 For recent reviews, see 11–13. More recently,
TMX3, a member of the thioredoxin family of proteins,
was shown to be mutated in unilateral microphthalmia.14
At least ten forms of syndromic microphthalmia
have been reported so far: MCOPS1 (MIM 309800), Lenz
microphthalmia;15 MCOPS2 (MIM 300166), oculo-facio-
cardio-dental syndrome;16 MCOPS3 (MIM 206900), anoph-
thalmia-esophageal-genital syndrome;7 MCOPS4 (MIM
301590), microphthalmia-ankyloblepharon-mental retar-
dation;17 MCOPS5 (MIM 610125), microphthalmia-optic
nerve agenesis, corpus callosum agenesis, joint laxity;6
MCOPS6 (MIM 607932), microphthalmia-pituitary anoma-
lies;18 MCOPS7 (MIM 309801), microphthalmia-dermal
aplasia-sclerocornea;19 MCOPS8 (MIM 601349), micro-
cephaly-microphthalmia-ectrodactyly of lower limbs-prog-
nathism;20 and MCOPS9 (MIM 601186), pulmonary
agenesis, microphthalmia-diaphragmatic defect.21 Several
of these entities have overlapping phenotypes, andwhether
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recessive anophthalmia with hand and foot malforma-
tions.22 This syndrome (Waardenburg anophthalmia
syndrome, also known as microphthalmia with limb
anomalies, ophthalmoacromelic syndrome, and anoph-
thalmia-syndactyly [MIM 206920]) is characterized by
unilateral or bilateral microphthalmia, clinical anophthal-
mia, syndactyly, polydactyly, synostosis, and/or oligodac-
tyly. In addition, other organs may be affected (long-
bone hypoplasia; renal, venous, and vertebral anomalies).
Most patients are mentally retarded and are born from
consanguineous parents. Since the first description by
Waardenburg, more than 35 cases have been identi-
fied.22–30 Recently, Hamanoue et al. used homozygosity
mapping to identify a 433 kb homozygous region on chro-
mosome 10p11.23 between STS9 and STS12, but no
mutated gene was identified.31
We report on a consanguineous family of Egyptian origin
with four children, two of whom are affected with Waarden-
burg anophtalmia syndrome (Figure 1). The first child
(V.2 in Figure 1), born to healthy parents, was a 12-yr-old
girl when last seen at our clinics. At birth, her father (IV.7)
was 33 yr old and her mother (IV.8) 30 yr old. The second
affected child (V.4) was 8 yr old. Both were born at full term
after an uneventful pregnancy and anuncomplicated vaginal
delivery. Birthweightswerewithin normal limits, but lengths
are unknown. Both had global delay in developmental mile-
stones: responsive smile was first seen at 10 and 8 mo in
patients V.2 and V.4, respectively, and they walked at 3 yr.
A Binet test performed on V.4 at 7 yr of age gave a score of
80, and her older sister was similarly mentally retarded.
On clinical examination, both had broad lateral eyebrows,
sparse eyelashes, short palpebral fissures, and bilateral-Gonin Eye Hospital, University of Lausanne, 1003 Lausanne; 3Department
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Figure 1. Clinical and X-Ray Evaluation
of the Patients
(A) Image of the orbit of patient V.2. Note
the short palpebral fissure, broad lateral
eyebrows, and sparse eyelashes.
(B) Transpalpebral ultrasonography (12
MHz) in the same child, showing the
absence of eye or cystic remnants.
(C) Hands of the same patient, with prox-
imal placement of thumb, and F5 radial
clinodactyly.
(D) X-ray images of the hands, high-
lighting proximal placement of the
thumb, F45 osseous syndactyly, F5 radial
clinodactyly, and fusion of the capitate
and hamate carpal bones.
(E) Feet of the same child, showing an
absent ray with sandal gap and pes pla-
num.
(F) X-rays of the feet showing, in addition,
bilateral partial fusion of both the middle
and the medial cuneiform bones.anophthalmia (Figure 1A). Transpalpebral ultrasonography
(12 MHz) (Figure 1B) and ultrasound biomicroscopy (50
MHz) confirmed the absence of an eye globe in both affected
individuals, and no cysts were observed. Clinically observed
skeletal abnormalities included malar flattening, a high
palate, bilateral proximal placement of the thumb, bilateral
F45 osseous syndactyly, bilateral F5 radial clinodactyly, bilat-
eral camptodactyly of F15 (Figures 1C and 1D), an absent
ray in both feet with sandal gap and pes planum (Figure 1e),
and mild scoliosis in both affected children. Hand and wrist
X-rays (Figure1D) revealed fusionof thecarpalbones (capitate
and hamate). Elbow X-rays were normal. X-rays of the feet
(Figure 1F) and legs showed bilateral partial fusion of both
middle and medial cuneiform bones, an absent ray, and
normal tibia and fibula. These features were common to
both patients. Orbital and brain MRI scans were performed
in both girls as well. No eye globe or cysts were reported on
orbital MRI, but extraocular muscles normal in signal and
size were present. On brain MRI, complete absence of the
optic nerves, chiasma, and optic tracts was observed, and noThe American Journal of Humaother malformations were noted, espe-
cially of the corpus callosum and pitui-
tary gland. The karyotype was normal
(46,XX) in both patients, as was the
renal ultrasound examination. The
pedigree is described in Figure 2. This
study was approved by the ethics
committees of the Faculty of Medicine,
University of Alexandria and the
Faculty of Biology and Medicine,
University of Lausanne.
Homozygous mapping via the
Human660W-Quad DNA Analysis
BeadChip (Illumina) was performed
on individuals IV.7, IV.8, V.2, V.3,and V.4. We first concentrated on the region around
the membrane protein palmitoylated 7 gene (MPP7
[MIM 610973]) that was reported to be a potential candi-
date on chromosome 10.31 However, the largest homozy-
gous stretch of DNA in that region was only 60 kb. There-
fore, the molecular anomaly involved in the family that
we describe must be located elsewhere. Analysis of the
rest of the data identified several homozygous regions in
the genome of the patients, but many were also present
in the nonaffected sibling and were therefore discarded.
Three regions of homozygosity larger than 1 Mb and
specific to the two patients were identified (Table S1, avail-
able online). The largest region was located between
rs11158442 (position 62,198,792) and rs4899594 (posi-
tion 76,031,821), defining a 14 Mb region on chromo-
some 14q23. Two genes in which mutations had already
been implicated in microphthalmia and anophthalmia,
BMP4 (MIM 112262) and OTX2 (MIM 600037), were
located close to the homozygous region but were clearly
outside of it.6,32 According to Ensembl, this intervaln Genetics 88, 92–98, January 7, 2011 93
Figure 2. Pedigree and Mutation Anal-
ysis
(A) Pedigree showing consanguinity.
(B) Electropherogram of part of SMOC1
exon 3 showing normal (1), heterozygous
(2), and homozygous (3) c.378þ1G>T
mutation.contains more than 100 protein-coding sequences. As its
name implies, the ophthalmo-acromelic syndrome shows
aberration in the development of the eyes and bones. We
therefore restricted the list of candidate genes to those ex-
pressed in the eyes, bones, and connective tissue. Expres-
sion of each candidate was checked in the EST profile of
the UniGene database. Thirty-three genes passed this
filter. Among these genes, MPP5 (MIM 606958), RDH11
(MIM 607849), ZFP36L1 (MIM 601064), SRSF5 (MIM
600914), SMOC1 (MIM 608488), and ZFYVE1 (MIM
605471) were further evaluated. MPP5
(ENSG00000072415) is a member of the peripheral
membrane-associated guanylate kinase (MAGUK) family
and may play a role in tight junction formation and
cell-polarity establishment. Interestingly, MPP7, another
member of the MAGUK family, was the only gene identi-
fied in the locus reported by Hamanoue et al.31 RDH11
(ENSG00000072042) is implicated in the reduction of
all-trans-retinal, a molecule with high relevancy to the
eye. The zinc finger protein 36, C3H type-like 1 gene
(ZFP36L1 [ENSG00000185650]) is a member of the
TIS11 family of early-response genes and is induced by,
among others, the polypeptide mitogen EGF. It could
thus regulate the response to growth factors. SRSF5
(ENSG00000100650) is a member of the serine- and argi-
nine-rich family of pre-mRNA splicing factors. Mutations
in splicing factors have been implicated in retinal pig-
mentosa. Zinc finger FYVE domain-containg protein 1
(ENSG00000165861) is a member of the FYVE domain
proteins. They mediate the recruitment of proteins
involved in membrane trafficking and cell signaling to
phophatidylinositol 3-phosphate-containing membranes.
Mutations in PIKFYVE, another member of the FYVE
domain proteins, are responsible for the Franc¸ois-Neetens
fleck corneal dystrophy (MIM 121850). Sequencing of the
exons and intron-exon boundaries of these genes did not
show any causative variants.94 The American Journal of Human Genetics 88, 92–98, January 7, 2011However, sequencing of SMOC1
(ENSG00000198732) revealed a
c.378þ1G>T (IVS3þ1G>T) mutation
in the canonical splice donor site of
intron 3 (Figure 2). Both parents
were heterozygous for this mutation,
and the only available non-affected
child was homozygous for the normal
sequence. This mutation was looked
for in 556 control chromosomes
from individuals of Egyptian, NorthAfrican, and European descent by denaturing high-perfor-
mance liquid chromatography and was never observed.
For primers used in SMOC1 sequencing, see the Supple-
mental Data.
SMOC1 (secreted modular calcium-binding 1) is a
48 kDa secreted modular protein containing an EF-hand
calcium-binding domain and is a member of the SPARC
family of proteins characterized by the presence of follista-
tin and EF-hand calcium-binding domains.33 Analysis of
the EST profile in UniGene indicates that it is widely
expressed, including in the eyes and bones. SMOC1 has
12 exons and several large introns. Intron 3 has a size of
22.2 kb, and a mutation in the canonical G nucleotide of
the splice donor might either greatly perturb mRNA
synthesis or activate nonsense-mediated decay. Unfortu-
nately, we were unable to amplify SMOC1 by using RT-PCR
with RNA extracted from normal blood and could not
therefore investigate whether nonsense-mediated decay
was happening or whether a truncated protein with an
aberrant C terminus was generated.
SMOC1 is well conserved among various species,
including zebrafish, in which we could identify a retired
contig containing the 30 region of a putative smoc1
(LOC795519). Protein-homology analysis between human
SMOC1 and the putative zebrafish smoc1 gave an overall
score of 63%, with some regions having a score over
80%. Except for the missing (or undiscovered) signal
peptide, the putative smoc1 has a structure very similar to
that of the human (see Figure S1). It also contains an FS
domain, two TY domains, and a C-terminal SPARC
calcium-binding domain containing two EF hands.
Compared to SMOC1, smoc1 contains an additional region
coding for a 27-amino-acid-long stretch between the FS
domain and the first TY domains, as well as a second,
17-amino acid-long region situated just after the first TY
domain and before the first SMOC1-specific domain
(Figure S1). Interestingly, the SMOC1-specific domains are
Figure 3. Expression of smoc1 in Zebra-
fish
(A–D) Whole-mount in situ hybridization
experiments showing early expression of
smoc1 in the brain (arrow) and in the ante-
rior retina (arrowhead) at 10 ss and 18 ss,
respectively.
(E and F) smoc1 is localized in the ventral
retina, on both sides of the choroid fissure
at 24 hr (E), and in the pharyngeal arches
at 48 hpf (F).
(A, C, E, and F) Top and left represent
dorsal and frontal parts of the animal. (B)
and (D) are top views. Magnification:
2003.also conserved in zebrafish. Database searching and PCR
amplifications using various primers located in the coding
regions of the gene allowed us to identify only one copy of
smoc1 in the D. rerio genome.
In order to evaluate the role of smoc1 in the develop-
ment of the eye, we first evaluated its expression in
zebrafish by in situ hybridization and then observed the
effect of a transient knockdown of its translation by using
a morpholino targeting the donor splice site of intron 3,
the location that is mutated in the patients.
On the basis of the sequence of LOC795519, we cloned,
after RT-PCR of zebrafish embryo mRNA using primers
F (50-ATGCC CTCAT CGCTT CAT-3) and R (50-CTAAC
CCTCC TTATT GACTCC-30), a 1359 bp cDNA coding for
453 amino acids. From this clone, we generated two
dioxygenin-labeled probes for in situ hybridization that
covered the 50 and 30 regions of smoc1 with primers
F100 (50-GGTTC AGACG GACGC AGTTATG-30) and
R628 (50-TCTGC CTCTC CTGGT CACAA-30 and F716
(50-GCCAC CAATC TACAG GTTAC-30) and R1063
(50-CGTGA CTGCC GTTAT TATCC-30), respectively. and
examined smoc1 expression in zebrafish embryos as
described previously.34 Expression of smoc1 by whole-The American Journal of Humamount in situ hybridization was first
evident at the 10-somite stage (10
ss). In the optic vesicles, transcripts
were first detected in the ventrolateral
diencephalon (Figures 3A and 3B),
then in the most anterior part of the
retina at 18 ss (Figures 3C and 3D).
At 24 and 48 hr postfertilization
(hpf), smoc1 was expressed in the
ventral retina, on both sides of the
choroid fissure (Figure 3E and 3F).
Signals were seen in the brain at 10
ss and 18 ss as well as in pharyngeal
arches at 48 hpf (Figure 3F). Func-
tional analysis of smoc1 was assessed
with the use of morpholino injec-
tions. Microinjections were per-
formed with a Femtojet (Eppendorf).
The smoc1 morpholino covering theexon 3-intron 3 splice site (50-CCGGA ACTCT GACAG
ACCTG AGCAA-30) was synthesized by Gene Tools. For
control injections, the standard control morpholino
provided by Gene Tools was used. The stock solutions
were diluted to 750 mM in H2O with 0.1% phenol red
(Acros Organics, Brunschwig AG). Two nanoliters were
injected in the yolk at 1- to 2-cell stage. First, efficiency
of the morpholino targeting the exon 3-intron 3 splice
site of smoc1 was controlled by RT-PCR with the use of
primers F100 and R628 (Figure 4B). Additional amplicons
larger and smaller than the normal 660 bp product were
observed. They may correspond to fragments containing
part of intron 3 or abnormal splice variants. Knockdown
of smoc1 revealed microphthalmia associated with defects,
especially in the ventral retina at 2 days postfertilization
(dpf): the choroid fissure remained widely open compared
to the untreated or control morpholino-injected larvae
(Figures 4A and 4B). The coloboma was no longer detect-
able at 5 dpf, but microphthalmia was still severe, and
the retina was especially underdeveloped at the ventral
and nasal parts of the eye (Figure 4C). Smoc1 may also be
important for brain development, because defects in the
forebrain were observed at 5 dpf (Figure 4C). Pharyngealn Genetics 88, 92–98, January 7, 2011 95
Figure 4. smoc1 Morpholino-Treated Embryos
(A and C) smoc1 morpholino-injected embryos
at 2 and 5 dpf, respectively.
(B and D) Control morpholino-injected embryo
at 2 dpf and wild-type embryo at 5 dpf. (B)
RT-PCR (þ indicates with reverse transcriptase;
- indicates without reverse transcriptase) on
mRNA of noninjected embryos (-), embryos
injected with smoc1 morpholino (MO), or those
injected with control morpholino (MO-Ct) at
1 dpf. smoc1 knockdown revealed microphthal-
mia with defects in the ventral retina associated
with abnormalities in brain development.
Control for RNA extraction and amplification
was performed with actin (PCR primers:
50-GGGAG TGATG GTTGG CATGG-30 and
50-AGGAA GGAAG GCTGG AAGAG-30).arches seemed to be underdeveloped as well, but additional
studies will be needed to confirm this.
The exact role of SMOC1 is still poorly understood. It
was identified through its homology with secreted protein
acidic and rich in cysteine (SPARC [MIM 182120]), also
known as osteonectin, a protein important for bone calci-
fication.35 Sparc-deficient mice show cataract and rupture
of the lens capsule around the age of 6 mo.36 SMOC1 is
localized in many tissues, where it associates with base-
ment membranes, and interaction between the FS domain
and the EC domain influences calcium binding.37 Calcium
is critical for many developmental programs and is
required for continuous function of the visual cycle, in
which, among other roles, it regulates the guanylyl cyclase
activating protein (GUCA1A [MIM 600364]), a calcium-
binding protein with four EF-hand domains. Interestingly,
Jalili syndrome (MIM 217080), another malformation
syndrome affecting ocular development and the formation
of the tooth, a tissue closely related to bone, is due tomuta-
tions in CNNM4, a gene implicated in Ca2þ control
through Mg2þ exchange at GUCA1A.34 Novinec et al.
also showed that SMOC1 binds many proteins, including
C-reactive protein (CRP [MIM 123260]), fibulin-1 (MIM96 The American Journal of Human Genetics 88, 92–98, January 7, 2011135820), and vitronectin (MIM 193190).37
Fibulins are proteins involved in elastic-
fiber assembly, cell proliferation, migration,
adhesion, and angiogenesis, in which fibu-
lin-1 stabilizes newly formed blood
vessels.38,39 SMOC1 has also been involved
in osteoblast differentiation and SMOC1
knockdown by shRNA-inhibited minerali-
zation and expression of osteoblast-differ-
entiation markers in human bone-
marrow-derived mesenchymal stem cells.40
Interestingly, the same authors also identi-
fied EFEMP1 (MIM 601548), a member of
the fibulin family, as implicated in osteo-
blast differentiation. Mutation in EFEMP1
causes malattia leventinese or Doyne
honeycomb retinal dystrophy (MIM126600), a disease characterized by the early development
of drusen, similar to age-related macular degeneration.41 It
is not known how SMOC1 participates in the development
of bones, but on the basis of the phenotype associated with
Waardenburg anophthalmia, it may be required for proper
individualization of hand and foot rays.
In the zebrafish, smoc1 is highly expressed in the brain,
choroidal fissure, pharyngeal arches, and somites. Knock-
down experiments showed a coloboma at 2 dpf. At 5 dpf,
the eye was microphthalmic and the brain showed gross
malformations. Additional studies need to be done to see
whether it is also implicated in the development of fin
rays. Our analysis showed that Waardenburg anophthal-
mia syndrome is genetically heterogeneous. In addition
to the previously described locus on chromosome 10, we
identified a second locus on chromosome 14 and showed
that mutations in SMOC1 also cause this syndrome.Supplemental Data
Supplemental Data include one figure and two tables and can be
found with this article online at http://www.cell.com/AJHG/.
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